Laporan Sela Getinge Juli-September 2026: Profitabilitas meningkat, arus kas kuat, dan kepuasan pelanggan lebih tinggi
Getinge merilis laporan selanya untuk periode Juli hingga September 2026, menunjukkan peningkatan profitabilitas dan arus kas yang kuat. Perusahaan teknologi medis ini juga melaporkan pertumbuhan organik positif baik dalam penerimaan pesanan maupun penjualan secara keseluruhan.
Getinge published its interim financial results for the third quarter of 2026, highlighting robust performance across multiple key operational metrics. The medical technology firm successfully delivered positive organic growth in both order intake and net sales during the period. Furthermore, strategic cost management initiatives allowed the company to expand its profitability margins and generate solid free cash flow. Customer satisfaction scores also trended higher, reflecting successful execution in healthcare product delivery and service quality. Leadership expressed satisfaction with the resilience of the business despite lingering macroeconomic pressures in global healthcare markets. Investors responded favorably to the balanced combination of top-line expansion and disciplined financial stewardship.
Penafian analisis AI
Analisis dampak aset dibuat oleh AI dan hanya untuk tujuan informasi. Ini bukan nasihat keuangan. Selalu lakukan riset sendiri sebelum mengambil keputusan investasi.
Diskusi